The most successful supplement brands are already changing how they innovate; but not in the ways many expect.
After more than 30 years in the industry, TSI Group’s co‑founders Joe Zhou and Larry Kolb have seen first-hand which innovation shifts separate brands that adapt from those that fall behind.
This perspective has revealed three changes now shaping whether supplements succeed or stall:
- Adherence‑driven delivery format design
- Root‑cause formulation grounded in science
- Personalised nutrition as a growth strategy
1. Adherence becomes the real measure of efficacy
In the coming years, efficacy will increasingly be judged less by what a formulation contains, and more by whether consumers actually use it consistently.
This shift is already shaping R&D decision‑making. Large capsules, unpleasant tastes and inconvenient formats are now recognised as commercial risks, not minor formulation trade‑offs. As a result, delivery format is becoming a strategic lever – one that directly affects repeat purchase, brand trust and long‑term product performance.
For innovation leaders, this changes how development starts.
What this means in practice:
- Delivery format selection must happen earlier in the development process
- Ingredients need to be evaluated not just for bioactivity, but for format flexibility and sensory performance
- Processing, optimisation and taste-masking capabilities are becoming as important as ingredient sourcing
Formats such as fast‑melt powders, chewables, granules and functional beverages are no longer niche. They are becoming default expectations in categories ranging from sports nutrition to healthy ageing.
2. Root‑cause formulation replaces generic claims
The second major shift is the move away from generic, ingredient-stacked formulations towards root‑cause‑driven nutrition strategies.
Today’s consumers are more educated, and more skeptical. They want to understand not only what a product does, but why it works. This expectation is pushing brands to design formulations that address underlying physiological mechanisms rather than stacking familiar ingredients around broad claims.
For R&D teams, this creates both opportunity and complexity:
- Greater need for scientific logic and substantiation
- Increased pressure to align formulation decisions with regulatory and claims strategy
- Stronger reliance on expert advisory input earlier to guide development choices
Rather than starting with a trending ingredient, product development teams need to start with questions like:
- Which biological pathway is being targeted?
- What combination of nutrients, formats and dosages best support that mechanism?
This approach changes how teams collaborate. It demands stronger integration between formulation scientists, functional health experts and development partners – breaking down silos that have traditionally slowed innovation.
3. Personalised nutrition moves from concept to competitive advantage
While root‑cause science defines what to target, personalised nutrition defines how precisely that solution is delivered to the individual.
What was once viewed as futuristic or niche is becoming a practical strategy to improve engagement, loyalty and long‑term differentiation.
Personalised nutrition moves beyond broad segmentation towards person‑specific supplementation built from health data that’s designed to evolve as needs change. The approach:
- Replaces “one‑size‑fits‑all” products with made‑to‑order formulas, grounded in practitioner‑guided, evidence‑based protocols
- Consolidates complex regimens into single, once‑daily delivery formats, reducing supplement fatigue and improving compliance
- Creates formulations that are no longer static and adapt over time based on health goals, biomarkers or expert input
For brands, the challenge is execution and access: ensuring personalisation does not add unsustainable complexity, regulatory risk or development drag. That makes early design decisions, and the right development partners with global manufacturing capabilities, critical.
Advanced personalisation platforms, such as TSI Group’s Tailored Script®, demonstrate how this can work in practice. The novel platform is already being used by brands around the world to integrate health data, formulation science and precision delivery into a repeatable system.
The takeaway is clear: personalisation delivers value when it is designed as a system that integrates data, formulation science, delivery format and manufacturing strategy into a repeatable, scalable model.
Why these three trends now define survival – not just success
Brands that fail to integrate these shifts often encounter familiar pitfalls: products consumers do not use, claims that are difficult to defend, or innovations that stall during scale‑up.
For leaders planning the next three to five years, this means asking harder questions earlier:
- Are pipelines designed for real‑world use, not ideal conditions?
- Are formulations addressing underlying health challenges – or just following ingredient trends?
- Is personalisation being built deliberately, or added reactively?
Answering these questions requires more than internal expertise. It requires collaboration with partners that understand how formulation science, delivery technology and development realities intersect.
Partner choice will shape the next generation of supplements
As supplement innovation becomes more complex, the role of external partners is evolving. Brands increasingly need ingredient suppliers and manufacturing partners that go beyond catalogues and production capacity.
Today’s challenges demand collaborators that can actively support decision‑making, help reduce risk, shorten timelines and manage uncertainty across the entire development lifecycle.
To stay competitive, brands need to work with partners that can:
- Translate functional health insights into viable, substantiated formulations
- Enable flexible, consumer‑friendly delivery formats that support adherence
- Anticipate scale‑up and regulatory challenges earlier
- Reduce risk and shorten timelines across the development lifecycle
This shift is driving brands towards end‑to‑end solution providers such as TSI Group. The company is an example of a development partner that offers a combination of proven ingredients, root‑cause formulations developed with scientific advisors, manufacturing capabilities, differentiated delivery formats, a personalised nutrition platform and full commercialisation and regulatory support.
In this environment, competitive advantage belongs to those who build connected ecosystems – not just isolated pipelines.
The bottom line
According to TSI experts, the future of supplements will not be defined by any single ingredient, format or trend. It will be shaped by how effectively brands combine scientific credibility, consumer usability and strategic relevance.
For supplement brands navigating limited time and rising expectations, the priority is clear: focus on what improves adherence, formulate for root causes, and apply personalization with purpose.
Vitafoods Europe 2026 offers a real‑time view of how these critical shifts are reshaping supplement innovation. The event will provide an opportunity to explore how these principles are being applied in practice – and to engage directly with experts who have spent decades navigating the shifts now defining the next era of supplement innovation.
